nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2A—phrenic nerve—lung cancer	0.0646	0.373	CbGeAlD
Amisulpride—HTR7—pulmonary artery—lung cancer	0.0376	0.217	CbGeAlD
Amisulpride—HTR2A—pulmonary artery—lung cancer	0.0234	0.135	CbGeAlD
Amisulpride—HTR7—respiratory system—lung cancer	0.00632	0.0365	CbGeAlD
Amisulpride—DRD2—respiratory system—lung cancer	0.00598	0.0345	CbGeAlD
Amisulpride—HTR7—epithelium—lung cancer	0.00528	0.0305	CbGeAlD
Amisulpride—HTR7—trachea—lung cancer	0.00467	0.027	CbGeAlD
Amisulpride—HTR2A—respiratory system—lung cancer	0.00394	0.0228	CbGeAlD
Amisulpride—HTR2B—lung—lung cancer	0.00392	0.0226	CbGeAlD
Amisulpride—HTR7—lung—lung cancer	0.00336	0.0194	CbGeAlD
Amisulpride—HTR2A—epithelium—lung cancer	0.00329	0.019	CbGeAlD
Amisulpride—DRD2—lung—lung cancer	0.00317	0.0183	CbGeAlD
Amisulpride—HTR2A—trachea—lung cancer	0.00291	0.0168	CbGeAlD
Amisulpride—HTR2B—lymph node—lung cancer	0.00268	0.0155	CbGeAlD
Amisulpride—HTR2A—lung—lung cancer	0.00209	0.0121	CbGeAlD
Amisulpride—Hypersensitivity—Topotecan—lung cancer	0.00109	0.00159	CcSEcCtD
Amisulpride—Tremor—Cisplatin—lung cancer	0.00108	0.00159	CcSEcCtD
Amisulpride—Angiopathy—Paclitaxel—lung cancer	0.00108	0.00159	CcSEcCtD
Amisulpride—Constipation—Vinorelbine—lung cancer	0.00108	0.00158	CcSEcCtD
Amisulpride—Immune system disorder—Paclitaxel—lung cancer	0.00108	0.00158	CcSEcCtD
Amisulpride—Hypertension—Gemcitabine—lung cancer	0.00107	0.00157	CcSEcCtD
Amisulpride—Asthenia—Topotecan—lung cancer	0.00106	0.00155	CcSEcCtD
Amisulpride—Agranulocytosis—Docetaxel—lung cancer	0.00105	0.00154	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00105	0.00154	CcSEcCtD
Amisulpride—Asthenia—Erlotinib—lung cancer	0.00105	0.00153	CcSEcCtD
Amisulpride—Mental disorder—Paclitaxel—lung cancer	0.00105	0.00153	CcSEcCtD
Amisulpride—Pruritus—Topotecan—lung cancer	0.00104	0.00153	CcSEcCtD
Amisulpride—Malnutrition—Paclitaxel—lung cancer	0.00104	0.00152	CcSEcCtD
Amisulpride—Diarrhoea—Vinblastine—lung cancer	0.00104	0.00152	CcSEcCtD
Amisulpride—Leukopenia—Cisplatin—lung cancer	0.00104	0.00152	CcSEcCtD
Amisulpride—Pruritus—Erlotinib—lung cancer	0.00103	0.00151	CcSEcCtD
Amisulpride—Gastrointestinal pain—Vinorelbine—lung cancer	0.00103	0.00151	CcSEcCtD
Amisulpride—Nervous system disorder—Irinotecan—lung cancer	0.00102	0.0015	CcSEcCtD
Amisulpride—Tension—Paclitaxel—lung cancer	0.00102	0.0015	CcSEcCtD
Amisulpride—Muscle spasms—Etoposide—lung cancer	0.00102	0.00149	CcSEcCtD
Amisulpride—Nervousness—Paclitaxel—lung cancer	0.00101	0.00148	CcSEcCtD
Amisulpride—Diarrhoea—Topotecan—lung cancer	0.00101	0.00148	CcSEcCtD
Amisulpride—Hyperhidrosis—Irinotecan—lung cancer	0.00101	0.00147	CcSEcCtD
Amisulpride—Dizziness—Vinblastine—lung cancer	0.001	0.00147	CcSEcCtD
Amisulpride—Convulsion—Cisplatin—lung cancer	0.001	0.00147	CcSEcCtD
Amisulpride—Urticaria—Vinorelbine—lung cancer	0.001	0.00147	CcSEcCtD
Amisulpride—Muscle spasms—Paclitaxel—lung cancer	0.001	0.00147	CcSEcCtD
Amisulpride—Diarrhoea—Erlotinib—lung cancer	0.000998	0.00146	CcSEcCtD
Amisulpride—Abdominal pain—Vinorelbine—lung cancer	0.000997	0.00146	CcSEcCtD
Amisulpride—Nervous system disorder—Gemcitabine—lung cancer	0.000994	0.00146	CcSEcCtD
Amisulpride—Skin disorder—Gemcitabine—lung cancer	0.000984	0.00144	CcSEcCtD
Amisulpride—Anxiety—Cisplatin—lung cancer	0.000982	0.00144	CcSEcCtD
Amisulpride—Hyperhidrosis—Gemcitabine—lung cancer	0.00098	0.00144	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000979	0.00143	CcSEcCtD
Amisulpride—Dizziness—Topotecan—lung cancer	0.000975	0.00143	CcSEcCtD
Amisulpride—Tremor—Paclitaxel—lung cancer	0.000974	0.00143	CcSEcCtD
Amisulpride—Hypotension—Irinotecan—lung cancer	0.000972	0.00142	CcSEcCtD
Amisulpride—Vomiting—Vinblastine—lung cancer	0.000965	0.00141	CcSEcCtD
Amisulpride—Dizziness—Erlotinib—lung cancer	0.000965	0.00141	CcSEcCtD
Amisulpride—Agitation—Paclitaxel—lung cancer	0.000955	0.0014	CcSEcCtD
Amisulpride—Headache—Vinblastine—lung cancer	0.000951	0.00139	CcSEcCtD
Amisulpride—Angioedema—Paclitaxel—lung cancer	0.00095	0.00139	CcSEcCtD
Amisulpride—Leukopenia—Etoposide—lung cancer	0.000949	0.00139	CcSEcCtD
Amisulpride—Hypotension—Gemcitabine—lung cancer	0.000947	0.00139	CcSEcCtD
Amisulpride—Insomnia—Irinotecan—lung cancer	0.000941	0.00138	CcSEcCtD
Amisulpride—Cardiac disorder—Docetaxel—lung cancer	0.00094	0.00138	CcSEcCtD
Amisulpride—Vomiting—Topotecan—lung cancer	0.000938	0.00137	CcSEcCtD
Amisulpride—Leukopenia—Paclitaxel—lung cancer	0.000931	0.00136	CcSEcCtD
Amisulpride—Hypersensitivity—Vinorelbine—lung cancer	0.000929	0.00136	CcSEcCtD
Amisulpride—Vomiting—Erlotinib—lung cancer	0.000928	0.00136	CcSEcCtD
Amisulpride—Nervous system disorder—Cisplatin—lung cancer	0.000926	0.00136	CcSEcCtD
Amisulpride—Somnolence—Irinotecan—lung cancer	0.000925	0.00136	CcSEcCtD
Amisulpride—Headache—Topotecan—lung cancer	0.000924	0.00135	CcSEcCtD
Amisulpride—Convulsion—Etoposide—lung cancer	0.000919	0.00135	CcSEcCtD
Amisulpride—Angiopathy—Docetaxel—lung cancer	0.000918	0.00135	CcSEcCtD
Amisulpride—Skin disorder—Cisplatin—lung cancer	0.000918	0.00134	CcSEcCtD
Amisulpride—Insomnia—Gemcitabine—lung cancer	0.000917	0.00134	CcSEcCtD
Amisulpride—Dyspepsia—Irinotecan—lung cancer	0.000916	0.00134	CcSEcCtD
Amisulpride—Hypertension—Etoposide—lung cancer	0.000915	0.00134	CcSEcCtD
Amisulpride—Immune system disorder—Docetaxel—lung cancer	0.000914	0.00134	CcSEcCtD
Amisulpride—Headache—Erlotinib—lung cancer	0.000914	0.00134	CcSEcCtD
Amisulpride—Hyperhidrosis—Cisplatin—lung cancer	0.000913	0.00134	CcSEcCtD
Amisulpride—Asthenia—Vinorelbine—lung cancer	0.000905	0.00133	CcSEcCtD
Amisulpride—Nausea—Vinblastine—lung cancer	0.000902	0.00132	CcSEcCtD
Amisulpride—Somnolence—Gemcitabine—lung cancer	0.000901	0.00132	CcSEcCtD
Amisulpride—Convulsion—Paclitaxel—lung cancer	0.000901	0.00132	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Irinotecan—lung cancer	0.000898	0.00132	CcSEcCtD
Amisulpride—Hypertension—Paclitaxel—lung cancer	0.000898	0.00132	CcSEcCtD
Amisulpride—Fatigue—Irinotecan—lung cancer	0.000897	0.00131	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000897	0.00131	CcSEcCtD
Amisulpride—Pruritus—Vinorelbine—lung cancer	0.000893	0.00131	CcSEcCtD
Amisulpride—Constipation—Irinotecan—lung cancer	0.00089	0.0013	CcSEcCtD
Amisulpride—Mental disorder—Docetaxel—lung cancer	0.000887	0.0013	CcSEcCtD
Amisulpride—Hypotension—Cisplatin—lung cancer	0.000883	0.00129	CcSEcCtD
Amisulpride—Anxiety—Paclitaxel—lung cancer	0.000882	0.00129	CcSEcCtD
Amisulpride—Malnutrition—Docetaxel—lung cancer	0.000881	0.00129	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000879	0.00129	CcSEcCtD
Amisulpride—Nausea—Topotecan—lung cancer	0.000876	0.00128	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000875	0.00128	CcSEcCtD
Amisulpride—Fatigue—Gemcitabine—lung cancer	0.000874	0.00128	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—lung cancer	0.000868	0.00127	CcSEcCtD
Amisulpride—Constipation—Gemcitabine—lung cancer	0.000867	0.00127	CcSEcCtD
Amisulpride—Nausea—Erlotinib—lung cancer	0.000867	0.00127	CcSEcCtD
Amisulpride—Dry mouth—Paclitaxel—lung cancer	0.000866	0.00127	CcSEcCtD
Amisulpride—Diarrhoea—Vinorelbine—lung cancer	0.000863	0.00127	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—lung cancer	0.000852	0.00125	CcSEcCtD
Amisulpride—Gastrointestinal pain—Irinotecan—lung cancer	0.000851	0.00125	CcSEcCtD
Amisulpride—Muscle spasms—Docetaxel—lung cancer	0.000847	0.00124	CcSEcCtD
Amisulpride—Skin disorder—Etoposide—lung cancer	0.000841	0.00123	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—lung cancer	0.00084	0.00123	CcSEcCtD
Amisulpride—Hyperhidrosis—Etoposide—lung cancer	0.000837	0.00123	CcSEcCtD
Amisulpride—Dizziness—Vinorelbine—lung cancer	0.000834	0.00122	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—lung cancer	0.000834	0.00122	CcSEcCtD
Amisulpride—Nervous system disorder—Paclitaxel—lung cancer	0.000832	0.00122	CcSEcCtD
Amisulpride—Skin disorder—Paclitaxel—lung cancer	0.000824	0.00121	CcSEcCtD
Amisulpride—Abdominal pain—Irinotecan—lung cancer	0.000822	0.00121	CcSEcCtD
Amisulpride—Hyperhidrosis—Paclitaxel—lung cancer	0.00082	0.0012	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Cisplatin—lung cancer	0.000816	0.0012	CcSEcCtD
Amisulpride—Depression—Methotrexate—lung cancer	0.00081	0.00119	CcSEcCtD
Amisulpride—Hypotension—Etoposide—lung cancer	0.000809	0.00119	CcSEcCtD
Amisulpride—Vomiting—Vinorelbine—lung cancer	0.000802	0.00118	CcSEcCtD
Amisulpride—Hypotension—Paclitaxel—lung cancer	0.000793	0.00116	CcSEcCtD
Amisulpride—Headache—Vinorelbine—lung cancer	0.00079	0.00116	CcSEcCtD
Amisulpride—Leukopenia—Docetaxel—lung cancer	0.000789	0.00116	CcSEcCtD
Amisulpride—Somnolence—Etoposide—lung cancer	0.000769	0.00113	CcSEcCtD
Amisulpride—Insomnia—Paclitaxel—lung cancer	0.000767	0.00112	CcSEcCtD
Amisulpride—Hypersensitivity—Irinotecan—lung cancer	0.000767	0.00112	CcSEcCtD
Amisulpride—Convulsion—Docetaxel—lung cancer	0.000764	0.00112	CcSEcCtD
Amisulpride—Hypertension—Docetaxel—lung cancer	0.000761	0.00112	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—lung cancer	0.000758	0.00111	CcSEcCtD
Amisulpride—Somnolence—Paclitaxel—lung cancer	0.000754	0.00111	CcSEcCtD
Amisulpride—Nausea—Vinorelbine—lung cancer	0.000749	0.0011	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Etoposide—lung cancer	0.000747	0.0011	CcSEcCtD
Amisulpride—Dyspepsia—Paclitaxel—lung cancer	0.000747	0.00109	CcSEcCtD
Amisulpride—Asthenia—Irinotecan—lung cancer	0.000746	0.00109	CcSEcCtD
Amisulpride—Fatigue—Etoposide—lung cancer	0.000746	0.00109	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000745	0.00109	CcSEcCtD
Amisulpride—Constipation—Etoposide—lung cancer	0.00074	0.00108	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—lung cancer	0.000738	0.00108	CcSEcCtD
Amisulpride—Dry mouth—Docetaxel—lung cancer	0.000734	0.00108	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000733	0.00107	CcSEcCtD
Amisulpride—Fatigue—Paclitaxel—lung cancer	0.000732	0.00107	CcSEcCtD
Amisulpride—Asthenia—Gemcitabine—lung cancer	0.000727	0.00107	CcSEcCtD
Amisulpride—Constipation—Paclitaxel—lung cancer	0.000726	0.00106	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—lung cancer	0.000718	0.00105	CcSEcCtD
Amisulpride—Pruritus—Gemcitabine—lung cancer	0.000717	0.00105	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—lung cancer	0.000714	0.00105	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—lung cancer	0.000712	0.00104	CcSEcCtD
Amisulpride—Diarrhoea—Irinotecan—lung cancer	0.000712	0.00104	CcSEcCtD
Amisulpride—Gastrointestinal pain—Etoposide—lung cancer	0.000708	0.00104	CcSEcCtD
Amisulpride—Nervous system disorder—Docetaxel—lung cancer	0.000705	0.00103	CcSEcCtD
Amisulpride—Skin disorder—Docetaxel—lung cancer	0.000699	0.00102	CcSEcCtD
Amisulpride—Hypersensitivity—Cisplatin—lung cancer	0.000696	0.00102	CcSEcCtD
Amisulpride—Gastrointestinal pain—Paclitaxel—lung cancer	0.000694	0.00102	CcSEcCtD
Amisulpride—Diarrhoea—Gemcitabine—lung cancer	0.000693	0.00102	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—lung cancer	0.00069	0.00101	CcSEcCtD
Amisulpride—Dizziness—Irinotecan—lung cancer	0.000688	0.00101	CcSEcCtD
Amisulpride—Urticaria—Etoposide—lung cancer	0.000688	0.00101	CcSEcCtD
Amisulpride—Abdominal pain—Etoposide—lung cancer	0.000684	0.001	CcSEcCtD
Amisulpride—Asthenia—Cisplatin—lung cancer	0.000678	0.000993	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—lung cancer	0.000677	0.000992	CcSEcCtD
Amisulpride—Urticaria—Paclitaxel—lung cancer	0.000674	0.000988	CcSEcCtD
Amisulpride—Hypotension—Docetaxel—lung cancer	0.000672	0.000985	CcSEcCtD
Amisulpride—Abdominal pain—Paclitaxel—lung cancer	0.000671	0.000983	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—lung cancer	0.000662	0.00097	CcSEcCtD
Amisulpride—Vomiting—Irinotecan—lung cancer	0.000662	0.00097	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—lung cancer	0.000659	0.000966	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—lung cancer	0.000657	0.000963	CcSEcCtD
Amisulpride—Headache—Irinotecan—lung cancer	0.000652	0.000955	CcSEcCtD
Amisulpride—Insomnia—Docetaxel—lung cancer	0.000651	0.000953	CcSEcCtD
Amisulpride—Diarrhoea—Cisplatin—lung cancer	0.000646	0.000947	CcSEcCtD
Amisulpride—Vomiting—Gemcitabine—lung cancer	0.000644	0.000944	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—lung cancer	0.000643	0.000943	CcSEcCtD
Amisulpride—Somnolence—Docetaxel—lung cancer	0.000639	0.000937	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—lung cancer	0.000639	0.000937	CcSEcCtD
Amisulpride—Hypersensitivity—Etoposide—lung cancer	0.000638	0.000935	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—lung cancer	0.000635	0.000931	CcSEcCtD
Amisulpride—Headache—Gemcitabine—lung cancer	0.000635	0.000931	CcSEcCtD
Amisulpride—Dyspepsia—Docetaxel—lung cancer	0.000633	0.000928	CcSEcCtD
Amisulpride—Hypersensitivity—Paclitaxel—lung cancer	0.000625	0.000916	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Docetaxel—lung cancer	0.000621	0.00091	CcSEcCtD
Amisulpride—Asthenia—Etoposide—lung cancer	0.000621	0.00091	CcSEcCtD
Amisulpride—Fatigue—Docetaxel—lung cancer	0.00062	0.000909	CcSEcCtD
Amisulpride—Nausea—Irinotecan—lung cancer	0.000618	0.000906	CcSEcCtD
Amisulpride—Constipation—Docetaxel—lung cancer	0.000615	0.000901	CcSEcCtD
Amisulpride—Pruritus—Etoposide—lung cancer	0.000612	0.000897	CcSEcCtD
Amisulpride—Asthenia—Paclitaxel—lung cancer	0.000609	0.000892	CcSEcCtD
Amisulpride—Nausea—Gemcitabine—lung cancer	0.000602	0.000882	CcSEcCtD
Amisulpride—Vomiting—Cisplatin—lung cancer	0.000601	0.00088	CcSEcCtD
Amisulpride—Pruritus—Paclitaxel—lung cancer	0.0006	0.00088	CcSEcCtD
Amisulpride—Diarrhoea—Etoposide—lung cancer	0.000592	0.000868	CcSEcCtD
Amisulpride—Gastrointestinal pain—Docetaxel—lung cancer	0.000588	0.000862	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—lung cancer	0.000586	0.000859	CcSEcCtD
Amisulpride—Diarrhoea—Paclitaxel—lung cancer	0.000581	0.000851	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—lung cancer	0.000573	0.00084	CcSEcCtD
Amisulpride—Dizziness—Etoposide—lung cancer	0.000572	0.000839	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—lung cancer	0.000571	0.000836	CcSEcCtD
Amisulpride—Abdominal pain—Docetaxel—lung cancer	0.000569	0.000833	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—lung cancer	0.000569	0.000833	CcSEcCtD
Amisulpride—Dizziness—Paclitaxel—lung cancer	0.000561	0.000822	CcSEcCtD
Amisulpride—Nausea—Cisplatin—lung cancer	0.000561	0.000822	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—lung cancer	0.000554	0.000811	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—lung cancer	0.00055	0.000807	CcSEcCtD
Amisulpride—Vomiting—Etoposide—lung cancer	0.00055	0.000806	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—lung cancer	0.00055	0.000806	CcSEcCtD
Amisulpride—Headache—Etoposide—lung cancer	0.000542	0.000795	CcSEcCtD
Amisulpride—Tension—Doxorubicin—lung cancer	0.00054	0.000791	CcSEcCtD
Amisulpride—Vomiting—Paclitaxel—lung cancer	0.00054	0.000791	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000537	0.000787	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—lung cancer	0.000534	0.000783	CcSEcCtD
Amisulpride—Headache—Paclitaxel—lung cancer	0.000532	0.000779	CcSEcCtD
Amisulpride—Hypersensitivity—Docetaxel—lung cancer	0.00053	0.000777	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—lung cancer	0.000529	0.000775	CcSEcCtD
Amisulpride—Asthenia—Docetaxel—lung cancer	0.000516	0.000756	CcSEcCtD
Amisulpride—Nausea—Etoposide—lung cancer	0.000514	0.000753	CcSEcCtD
Amisulpride—Pruritus—Docetaxel—lung cancer	0.000509	0.000746	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—lung cancer	0.000508	0.000745	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—lung cancer	0.000505	0.000741	CcSEcCtD
Amisulpride—Nausea—Paclitaxel—lung cancer	0.000504	0.000739	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—lung cancer	0.000504	0.000738	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—lung cancer	0.000501	0.000734	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—lung cancer	0.000492	0.000722	CcSEcCtD
Amisulpride—Diarrhoea—Docetaxel—lung cancer	0.000492	0.000721	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—lung cancer	0.000484	0.00071	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—lung cancer	0.000477	0.000698	CcSEcCtD
Amisulpride—Dizziness—Docetaxel—lung cancer	0.000476	0.000697	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—lung cancer	0.000475	0.000696	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—lung cancer	0.000469	0.000687	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—lung cancer	0.000467	0.000684	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000465	0.000682	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—lung cancer	0.000461	0.000675	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—lung cancer	0.000458	0.000671	CcSEcCtD
Amisulpride—Vomiting—Docetaxel—lung cancer	0.000457	0.00067	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—lung cancer	0.000456	0.000669	CcSEcCtD
Amisulpride—Headache—Docetaxel—lung cancer	0.000451	0.00066	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—lung cancer	0.000448	0.000656	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—lung cancer	0.000447	0.000655	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—lung cancer	0.00044	0.000645	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—lung cancer	0.000436	0.000639	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—lung cancer	0.000434	0.000636	CcSEcCtD
Amisulpride—Nausea—Docetaxel—lung cancer	0.000427	0.000626	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—lung cancer	0.000424	0.000621	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—lung cancer	0.000419	0.000615	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—lung cancer	0.000412	0.000604	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—lung cancer	0.00041	0.000601	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—lung cancer	0.000406	0.000595	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—lung cancer	0.000399	0.000585	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—lung cancer	0.000395	0.000579	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000388	0.000568	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—lung cancer	0.000387	0.000567	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—lung cancer	0.000384	0.000563	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—lung cancer	0.000382	0.00056	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—lung cancer	0.000372	0.000545	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—lung cancer	0.000367	0.000538	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—lung cancer	0.000367	0.000538	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—lung cancer	0.000357	0.000523	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—lung cancer	0.000355	0.00052	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—lung cancer	0.000355	0.00052	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—lung cancer	0.000343	0.000502	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—lung cancer	0.000331	0.000485	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—lung cancer	0.00033	0.000483	CcSEcCtD
Amisulpride—Headache—Methotrexate—lung cancer	0.000325	0.000476	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—lung cancer	0.000322	0.000472	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—lung cancer	0.000318	0.000465	CcSEcCtD
Amisulpride—Nausea—Methotrexate—lung cancer	0.000308	0.000451	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—lung cancer	0.000307	0.00045	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—lung cancer	0.000297	0.000435	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—lung cancer	0.000285	0.000418	CcSEcCtD
Amisulpride—Headache—Doxorubicin—lung cancer	0.000281	0.000412	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—lung cancer	0.000267	0.000391	CcSEcCtD
Amisulpride—HTR2B—Signaling by GPCR—NRAS—lung cancer	3.92e-05	0.000271	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—lung cancer	3.91e-05	0.000271	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGF—lung cancer	3.88e-05	0.000268	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1R—lung cancer	3.85e-05	0.000266	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—lung cancer	3.83e-05	0.000265	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAP2K1—lung cancer	3.8e-05	0.000263	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1R—lung cancer	3.79e-05	0.000262	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HES1—lung cancer	3.78e-05	0.000262	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CD—lung cancer	3.77e-05	0.000261	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—lung cancer	3.77e-05	0.000261	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—MAPK3—lung cancer	3.75e-05	0.00026	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—lung cancer	3.74e-05	0.000259	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—lung cancer	3.73e-05	0.000258	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HES1—lung cancer	3.72e-05	0.000257	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RAF1—lung cancer	3.71e-05	0.000257	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—KRAS—lung cancer	3.69e-05	0.000256	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BRAF—lung cancer	3.69e-05	0.000255	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2—lung cancer	3.66e-05	0.000253	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RAF1—lung cancer	3.65e-05	0.000253	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APC—lung cancer	3.65e-05	0.000252	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KIT—lung cancer	3.65e-05	0.000252	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—lung cancer	3.65e-05	0.000252	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—NRAS—lung cancer	3.65e-05	0.000252	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6R—lung cancer	3.64e-05	0.000252	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CREBBP—lung cancer	3.63e-05	0.000252	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—lung cancer	3.62e-05	0.000251	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGF—lung cancer	3.61e-05	0.00025	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—lung cancer	3.6e-05	0.000249	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—lung cancer	3.57e-05	0.000247	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—lung cancer	3.56e-05	0.000247	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK3—lung cancer	3.49e-05	0.000242	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—lung cancer	3.48e-05	0.000241	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—lung cancer	3.47e-05	0.00024	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAP2K1—lung cancer	3.47e-05	0.00024	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB3—lung cancer	3.46e-05	0.000239	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—lung cancer	3.45e-05	0.000239	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BRAF—lung cancer	3.43e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—lung cancer	3.42e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—lung cancer	3.41e-05	0.000236	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB3—lung cancer	3.4e-05	0.000235	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—lung cancer	3.39e-05	0.000235	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6R—lung cancer	3.39e-05	0.000234	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CREBBP—lung cancer	3.38e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MDM2—lung cancer	3.38e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—lung cancer	3.37e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAF1—lung cancer	3.37e-05	0.000233	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ERBB2—lung cancer	3.33e-05	0.000231	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—lung cancer	3.33e-05	0.00023	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—lung cancer	3.32e-05	0.00023	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—lung cancer	3.31e-05	0.000229	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MTOR—lung cancer	3.29e-05	0.000228	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—lung cancer	3.29e-05	0.000228	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—lung cancer	3.27e-05	0.000226	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—lung cancer	3.26e-05	0.000226	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAP2K1—lung cancer	3.23e-05	0.000223	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR1—lung cancer	3.22e-05	0.000223	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—lung cancer	3.21e-05	0.000222	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—lung cancer	3.18e-05	0.00022	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—lung cancer	3.17e-05	0.000219	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR1—lung cancer	3.17e-05	0.000219	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—lung cancer	3.16e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—lung cancer	3.14e-05	0.000217	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRAS—lung cancer	3.14e-05	0.000217	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—lung cancer	3.12e-05	0.000216	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—lung cancer	3.1e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MDM2—lung cancer	3.09e-05	0.000214	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAF1—lung cancer	3.08e-05	0.000213	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOA1—lung cancer	3.06e-05	0.000212	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—lung cancer	3.05e-05	0.000211	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ERBB2—lung cancer	3.04e-05	0.000211	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—lung cancer	3.03e-05	0.00021	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—lung cancer	3.02e-05	0.000209	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—lung cancer	3.02e-05	0.000209	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOA1—lung cancer	3.01e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—lung cancer	3e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MTOR—lung cancer	3e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—lung cancer	3e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—lung cancer	2.98e-05	0.000206	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—lung cancer	2.94e-05	0.000204	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JUN—lung cancer	2.94e-05	0.000203	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—lung cancer	2.89e-05	0.0002	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—lung cancer	2.88e-05	0.0002	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MDM2—lung cancer	2.87e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRAS—lung cancer	2.87e-05	0.000199	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAF1—lung cancer	2.86e-05	0.000198	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—lung cancer	2.86e-05	0.000198	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1A—lung cancer	2.85e-05	0.000197	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—lung cancer	2.84e-05	0.000197	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ERBB2—lung cancer	2.83e-05	0.000196	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MTOR—lung cancer	2.8e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—lung cancer	2.8e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—lung cancer	2.79e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APC—lung cancer	2.79e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KIT—lung cancer	2.79e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—NRAS—lung cancer	2.79e-05	0.000193	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—lung cancer	2.79e-05	0.000193	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—lung cancer	2.77e-05	0.000192	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—lung cancer	2.76e-05	0.000191	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGF—lung cancer	2.76e-05	0.000191	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—lung cancer	2.76e-05	0.000191	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—lung cancer	2.75e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APC—lung cancer	2.75e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KIT—lung cancer	2.75e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—NRAS—lung cancer	2.75e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—lung cancer	2.75e-05	0.00019	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGF—lung cancer	2.71e-05	0.000188	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EP300—lung cancer	2.71e-05	0.000188	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—lung cancer	2.69e-05	0.000186	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—lung cancer	2.69e-05	0.000186	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JUN—lung cancer	2.68e-05	0.000186	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK3—lung cancer	2.67e-05	0.000185	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRAS—lung cancer	2.67e-05	0.000185	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—lung cancer	2.66e-05	0.000184	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—lung cancer	2.63e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK3—lung cancer	2.63e-05	0.000182	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BRAF—lung cancer	2.62e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—lung cancer	2.61e-05	0.000181	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—lung cancer	2.61e-05	0.000181	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1A—lung cancer	2.6e-05	0.00018	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—lung cancer	2.6e-05	0.00018	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—lung cancer	2.59e-05	0.00018	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6R—lung cancer	2.59e-05	0.000179	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CREBBP—lung cancer	2.59e-05	0.000179	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BRAF—lung cancer	2.58e-05	0.000179	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—lung cancer	2.57e-05	0.000178	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—lung cancer	2.57e-05	0.000178	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—lung cancer	2.57e-05	0.000178	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—lung cancer	2.55e-05	0.000177	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6R—lung cancer	2.55e-05	0.000177	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CREBBP—lung cancer	2.55e-05	0.000176	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—lung cancer	2.54e-05	0.000176	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—lung cancer	2.54e-05	0.000176	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NRAS—lung cancer	2.53e-05	0.000175	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—lung cancer	2.53e-05	0.000175	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—lung cancer	2.5e-05	0.000173	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—lung cancer	2.5e-05	0.000173	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JUN—lung cancer	2.5e-05	0.000173	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EP300—lung cancer	2.48e-05	0.000171	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAP2K1—lung cancer	2.47e-05	0.000171	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—lung cancer	2.45e-05	0.00017	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	2.43e-05	0.000168	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAP2K1—lung cancer	2.43e-05	0.000168	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—lung cancer	2.43e-05	0.000168	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK3—lung cancer	2.43e-05	0.000168	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1A—lung cancer	2.42e-05	0.000168	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—lung cancer	2.42e-05	0.000167	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—lung cancer	2.41e-05	0.000167	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—lung cancer	2.41e-05	0.000167	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—lung cancer	2.4e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	2.39e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—lung cancer	2.36e-05	0.000164	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—lung cancer	2.36e-05	0.000163	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—lung cancer	2.36e-05	0.000163	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—lung cancer	2.34e-05	0.000162	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—lung cancer	2.32e-05	0.000161	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NRAS—lung cancer	2.32e-05	0.00016	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—lung cancer	2.31e-05	0.00016	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EP300—lung cancer	2.3e-05	0.000159	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—lung cancer	2.24e-05	0.000155	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK3—lung cancer	2.22e-05	0.000154	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—lung cancer	2.21e-05	0.000153	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MDM2—lung cancer	2.2e-05	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAF1—lung cancer	2.19e-05	0.000152	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—lung cancer	2.18e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—lung cancer	2.18e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	2.17e-05	0.00015	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB2—lung cancer	2.17e-05	0.00015	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MDM2—lung cancer	2.16e-05	0.00015	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—lung cancer	2.16e-05	0.00015	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—lung cancer	2.16e-05	0.000149	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAF1—lung cancer	2.16e-05	0.000149	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NRAS—lung cancer	2.15e-05	0.000149	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MTOR—lung cancer	2.14e-05	0.000148	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—lung cancer	2.14e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB2—lung cancer	2.13e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—lung cancer	2.11e-05	0.000146	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—lung cancer	2.1e-05	0.000146	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MTOR—lung cancer	2.1e-05	0.000146	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK3—lung cancer	2.06e-05	0.000143	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—lung cancer	2.06e-05	0.000142	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRAS—lung cancer	2.04e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—lung cancer	2.02e-05	0.00014	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRAS—lung cancer	2.01e-05	0.000139	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—lung cancer	2.01e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—lung cancer	2e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—lung cancer	1.99e-05	0.000138	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.99e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—lung cancer	1.97e-05	0.000136	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—lung cancer	1.96e-05	0.000136	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—lung cancer	1.96e-05	0.000136	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—lung cancer	1.95e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—lung cancer	1.95e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—lung cancer	1.94e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—lung cancer	1.94e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—lung cancer	1.93e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—lung cancer	1.92e-05	0.000133	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—lung cancer	1.91e-05	0.000133	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JUN—lung cancer	1.91e-05	0.000132	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—lung cancer	1.88e-05	0.00013	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JUN—lung cancer	1.88e-05	0.00013	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—lung cancer	1.86e-05	0.000129	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—lung cancer	1.85e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRAS—lung cancer	1.85e-05	0.000128	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.85e-05	0.000128	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—lung cancer	1.85e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—lung cancer	1.83e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—lung cancer	1.83e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.82e-05	0.000126	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—lung cancer	1.82e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—lung cancer	1.8e-05	0.000125	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—lung cancer	1.77e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.77e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—lung cancer	1.77e-05	0.000123	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EP300—lung cancer	1.76e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EP300—lung cancer	1.73e-05	0.00012	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—lung cancer	1.71e-05	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—lung cancer	1.7e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRAS—lung cancer	1.69e-05	0.000117	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—lung cancer	1.69e-05	0.000117	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—lung cancer	1.67e-05	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—lung cancer	1.65e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NRAS—lung cancer	1.65e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—lung cancer	1.65e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.64e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—lung cancer	1.64e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—lung cancer	1.63e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NRAS—lung cancer	1.62e-05	0.000112	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—lung cancer	1.62e-05	0.000112	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK3—lung cancer	1.58e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRAS—lung cancer	1.58e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.55e-05	0.000108	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—lung cancer	1.54e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—lung cancer	1.51e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—lung cancer	1.51e-05	0.000104	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—lung cancer	1.5e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—lung cancer	1.5e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—lung cancer	1.48e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—lung cancer	1.42e-05	9.82e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—lung cancer	1.4e-05	9.67e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—lung cancer	1.39e-05	9.63e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.3e-05	9.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.28e-05	8.88e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—lung cancer	1.26e-05	8.73e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—lung cancer	1.24e-05	8.59e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRAS—lung cancer	1.21e-05	8.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRAS—lung cancer	1.19e-05	8.22e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—lung cancer	1.15e-05	7.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—lung cancer	1.14e-05	7.86e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—lung cancer	1.07e-05	7.37e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—lung cancer	1.05e-05	7.25e-05	CbGpPWpGaD
